The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate

Jong Jin Won, Hyunchul Chung, Jae Mann Song

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

Purpose: The serum prostate specific antigen (PSA) level is known to be related with the total prostate and cancer volumes. After a transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH), a decrease in the serum PSA level is expected. We investigated the relationship between the resected prostate specimen weight and serum PSA level. Materials and methods: Between July 1998 and March 2003, 372 patients underwent a TURP for the treatment BPH. We performed studies, including digital rectal examination, urinary flow rate, international prostate symptom score, serum PSA levels, and transrectal ultrasound (TRUS) pre-and post-operatively. We compared the resected specimen weight of the prostate with the changes in the serum PSA level using correlation and regression tests as statistical methods. Results: Removal of 1gm of BPH tissue decreased the serum PSA the average level by 0.45±0.25ng/ml. In patients with BPH, there was a strong statistical correlation and a direct proportionality between the resected specimen weight and changes in the serum PSA level (p < 0.05). Using the above mentioned statistical methods, the formula y=2.389+0.158x (x=resected specimen weight, y=changes in serum PSA levels) was derived. However, there was no statistical correlation between the two factors in prostate cancer patients. Conclusions: An elevated serum PSA level in patients with BPH is mainly caused by the enlargement of the prostate transition zone. A statistically significant difference was noted between the pre-and post-operative serum PSA levels. However, in patients with prostate cancer, the serum PSA levels showed various postoperative changes. Some patients that underwent a TURP for BPH showed no match on the previously-mentioned formula, and these patients should be carefully followed up, with serum PSA level check-ups and/or a prostate biopsy considered.

Original languageEnglish
Pages (from-to)704-707
Number of pages4
JournalKorean Journal of Urology
Volume46
Issue number7
Publication statusPublished - 2005 Jul 1

Fingerprint

Transurethral Resection of Prostate
Prostate-Specific Antigen
Prostatic Hyperplasia
Serum
Prostate
Prostatic Neoplasms
Weights and Measures
Digital Rectal Examination

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Won, Jong Jin ; Chung, Hyunchul ; Song, Jae Mann. / The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate. In: Korean Journal of Urology. 2005 ; Vol. 46, No. 7. pp. 704-707.
@article{4b33c338713b4f5c937554cfaee8d5e2,
title = "The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate",
abstract = "Purpose: The serum prostate specific antigen (PSA) level is known to be related with the total prostate and cancer volumes. After a transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH), a decrease in the serum PSA level is expected. We investigated the relationship between the resected prostate specimen weight and serum PSA level. Materials and methods: Between July 1998 and March 2003, 372 patients underwent a TURP for the treatment BPH. We performed studies, including digital rectal examination, urinary flow rate, international prostate symptom score, serum PSA levels, and transrectal ultrasound (TRUS) pre-and post-operatively. We compared the resected specimen weight of the prostate with the changes in the serum PSA level using correlation and regression tests as statistical methods. Results: Removal of 1gm of BPH tissue decreased the serum PSA the average level by 0.45±0.25ng/ml. In patients with BPH, there was a strong statistical correlation and a direct proportionality between the resected specimen weight and changes in the serum PSA level (p < 0.05). Using the above mentioned statistical methods, the formula y=2.389+0.158x (x=resected specimen weight, y=changes in serum PSA levels) was derived. However, there was no statistical correlation between the two factors in prostate cancer patients. Conclusions: An elevated serum PSA level in patients with BPH is mainly caused by the enlargement of the prostate transition zone. A statistically significant difference was noted between the pre-and post-operative serum PSA levels. However, in patients with prostate cancer, the serum PSA levels showed various postoperative changes. Some patients that underwent a TURP for BPH showed no match on the previously-mentioned formula, and these patients should be carefully followed up, with serum PSA level check-ups and/or a prostate biopsy considered.",
author = "Won, {Jong Jin} and Hyunchul Chung and Song, {Jae Mann}",
year = "2005",
month = "7",
day = "1",
language = "English",
volume = "46",
pages = "704--707",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "7",

}

Won, JJ, Chung, H & Song, JM 2005, 'The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate', Korean Journal of Urology, vol. 46, no. 7, pp. 704-707.

The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate. / Won, Jong Jin; Chung, Hyunchul; Song, Jae Mann.

In: Korean Journal of Urology, Vol. 46, No. 7, 01.07.2005, p. 704-707.

Research output: Contribution to journal › Article

TY - JOUR

T1 - The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate

AU - Won, Jong Jin

AU - Chung, Hyunchul

AU - Song, Jae Mann

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Purpose: The serum prostate specific antigen (PSA) level is known to be related with the total prostate and cancer volumes. After a transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH), a decrease in the serum PSA level is expected. We investigated the relationship between the resected prostate specimen weight and serum PSA level. Materials and methods: Between July 1998 and March 2003, 372 patients underwent a TURP for the treatment BPH. We performed studies, including digital rectal examination, urinary flow rate, international prostate symptom score, serum PSA levels, and transrectal ultrasound (TRUS) pre-and post-operatively. We compared the resected specimen weight of the prostate with the changes in the serum PSA level using correlation and regression tests as statistical methods. Results: Removal of 1gm of BPH tissue decreased the serum PSA the average level by 0.45±0.25ng/ml. In patients with BPH, there was a strong statistical correlation and a direct proportionality between the resected specimen weight and changes in the serum PSA level (p < 0.05). Using the above mentioned statistical methods, the formula y=2.389+0.158x (x=resected specimen weight, y=changes in serum PSA levels) was derived. However, there was no statistical correlation between the two factors in prostate cancer patients. Conclusions: An elevated serum PSA level in patients with BPH is mainly caused by the enlargement of the prostate transition zone. A statistically significant difference was noted between the pre-and post-operative serum PSA levels. However, in patients with prostate cancer, the serum PSA levels showed various postoperative changes. Some patients that underwent a TURP for BPH showed no match on the previously-mentioned formula, and these patients should be carefully followed up, with serum PSA level check-ups and/or a prostate biopsy considered.

AB - Purpose: The serum prostate specific antigen (PSA) level is known to be related with the total prostate and cancer volumes. After a transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH), a decrease in the serum PSA level is expected. We investigated the relationship between the resected prostate specimen weight and serum PSA level. Materials and methods: Between July 1998 and March 2003, 372 patients underwent a TURP for the treatment BPH. We performed studies, including digital rectal examination, urinary flow rate, international prostate symptom score, serum PSA levels, and transrectal ultrasound (TRUS) pre-and post-operatively. We compared the resected specimen weight of the prostate with the changes in the serum PSA level using correlation and regression tests as statistical methods. Results: Removal of 1gm of BPH tissue decreased the serum PSA the average level by 0.45±0.25ng/ml. In patients with BPH, there was a strong statistical correlation and a direct proportionality between the resected specimen weight and changes in the serum PSA level (p < 0.05). Using the above mentioned statistical methods, the formula y=2.389+0.158x (x=resected specimen weight, y=changes in serum PSA levels) was derived. However, there was no statistical correlation between the two factors in prostate cancer patients. Conclusions: An elevated serum PSA level in patients with BPH is mainly caused by the enlargement of the prostate transition zone. A statistically significant difference was noted between the pre-and post-operative serum PSA levels. However, in patients with prostate cancer, the serum PSA levels showed various postoperative changes. Some patients that underwent a TURP for BPH showed no match on the previously-mentioned formula, and these patients should be carefully followed up, with serum PSA level check-ups and/or a prostate biopsy considered.

UR - http://www.scopus.com/inward/record.url?scp=23044501816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044501816&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 704

EP - 707

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 7

ER -

Won JJ, Chung H, Song JM. The significance of changes in serum prostate specific antigen levels after a transurethral resection of the prostate. Korean Journal of Urology. 2005 Jul 1;46(7):704-707.

Access to Document